Arrowhead Pharmaceuticals, Inc. (ARWR) vs Protagonist Therapeutics, Inc. (PTGX)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Protagonist Therapeutics, Inc. PTGX 128.75 −5.71%
Arrowhead Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. are of similar size ($8.8B and $8.3B). Arrowhead Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 106×. Protagonist Therapeutics, Inc. grew revenue faster over the last twelve months: 34.8% against 16.1%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −47.8%) and the higher return on invested capital (61.8% vs 0.00%). Across the 17 metrics below, Protagonist Therapeutics, Inc. leads on 12 and Arrowhead Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | ARWR | PTGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (33.82%) | 20.69% | 0.00% |
| Net margin | (47.79%) | 29.40% | 0.00% |
| Free cash flow margin | (11.22%) | 46.31% | 0.00% |
| Return on equity | (64.91%) | 10.98% | (56.36%) |
| Return on assets | (18.32%) | 10.34% | (48.04%) |
| Return on invested capital | 0.00% | 61.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack